- Home
- GOSS vs TRUE Comparison
GOSS vs TRUE Comparison
Compare GOSS & TRUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- TRUE
- Stock Information
- Founded
- GOSS 2015
- TRUE 2005
- Country
- GOSS United States
- TRUE United States
- Employees
- GOSS N/A
- TRUE N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- TRUE Computer Software: Programming Data Processing
- Sector
- GOSS Health Care
- TRUE Technology
- Exchange
- GOSS Nasdaq
- TRUE Nasdaq
- Market Cap
- GOSS 214.7M
- TRUE 295.4M
- IPO Year
- GOSS 2019
- TRUE 2014
- Fundamental
- Price
- GOSS $0.96
- TRUE $3.80
- Analyst Decision
- GOSS Strong Buy
- TRUE Strong Buy
- Analyst Count
- GOSS 5
- TRUE 2
- Target Price
- GOSS $9.20
- TRUE $3.75
- AVG Volume (30 Days)
- GOSS 910.5K
- TRUE 281.4K
- Earning Date
- GOSS 11-07-2024
- TRUE 11-04-2024
- Dividend Yield
- GOSS N/A
- TRUE N/A
- EPS Growth
- GOSS N/A
- TRUE N/A
- EPS
- GOSS N/A
- TRUE N/A
- Revenue
- GOSS $95,842,000.00
- TRUE $165,280,000.00
- Revenue This Year
- GOSS N/A
- TRUE $11.97
- Revenue Next Year
- GOSS N/A
- TRUE $18.40
- P/E Ratio
- GOSS N/A
- TRUE N/A
- Revenue Growth
- GOSS N/A
- TRUE 8.74
- 52 Week Low
- GOSS $0.45
- TRUE $1.76
- 52 Week High
- GOSS $1.60
- TRUE $4.05
- Technical
- Relative Strength Index (RSI)
- GOSS 48.30
- TRUE 72.21
- Support Level
- GOSS $0.93
- TRUE $3.60
- Resistance Level
- GOSS $1.09
- TRUE $3.46
- Average True Range (ATR)
- GOSS 0.05
- TRUE 0.15
- MACD
- GOSS -0.01
- TRUE 0.04
- Stochastic Oscillator
- GOSS 20.31
- TRUE 95.42
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. TrueCar enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar Certified Dealers.